Reaction #9823

Reaction equation

3-(2-bromo-phenyl)-3,4-dihydro-7-methanesulphonyl-1-methyl-pyrimido[4,5-d]pyrimidin-2(1H)-one

hydroxymethyl-6-amino-1,4-benzodioxane

material b

hydroxymethyl-6-amino-1,4-benzodioxane

HCl

TFA

→

title product

3-(2-bromo-phenyl)-7-(2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-ylamino)-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one

Solvents

NMP

Conditions

Workup

1. 1
   Extractionextracted with ethyl acetate
2. 2
   Extractionextracted with CH2Cl2
3. 3
   Otherevaporated
4. 4
   Otherwas suspended in CH2Cl2 at room temperature
5. 5
   Filtrationsolid impurities were filtered off
6. 6
   WashThe filtrate was washed again with water
7. 7
   Otherto remove remainders of NMP
8. 8
   Otherevaporated
9. 9
   OtherThe residue was triturated with water
10. 10
    Filtrationfiltered
11. 11
    Otherdried

Procedure

1.2 g 3-(2-bromo-phenyl)-3,4-dihydro-7-methanesulphonyl-1-methyl-pyrimido[4,5-d]pyrimidin-2(1H)-one and 1.54 g 2 hydroxymethyl-6-amino-1,4-benzodioxane (starting material b)) were mixed in 20 ml NMP. 0.348 g TFA were added and the mixture was heated to 140° C. for 7 hrs. The mixture was poured into 10% aqueous HCl and extracted with ethyl acetate. The aqueous phase was adjusted to pH>9 and extracted with CH2Cl2. The organic phases were combined and evaporated. The residue was suspended in CH2Cl2 at room temperature and solid impurities were filtered off. The filtrate was washed again with water to remove remainders of NMP, then evaporated. The residue was triturated with water, filtered and dried to give 0.6 g of the title product (mp: 156–158° C.). NMR (CDCl3, δ in ppm): 2.03 (broad s, 1 H); 3.48 (s, 3H); 3.89 (dd, 1H); 3.95 (dd, 1H); 4.15 (dd, 1H); 4.28 (m, 1H); 4.33 (dd, 1H); 4.55 (d, 1H); 4.71 (d, 1H); 6.89 (m, 1H); 6.98 (m, 2H); 7.25 (m, 1H); 7.40 (m, 3H); 7.71 (d, 1H); 7.98 (s, 1H). MS (APCI+): 498 (M+1), 420 (M-Br)

Source